⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL29557677 | 0.97 | — | — | |
| Ethane SCHEMBL7904855 | 0.95 | — | — | |
| SCHEMBL8593395 | 0.90 | ALDH1A1 (0.30) | — | |
| SCHEMBL10758520 | 0.83 | — | — | |
| SCHEMBL997657 | 0.81 | ALDH1A1 (0.40) | — | |
| SCHEMBL28460072 | 0.79 | TSHR (0.38) | — | |
| SCHEMBL5104573 | 0.79 | TSHR (0.38) | — | |
| SCHEMBL11221322 | 0.78 | ALDH1A1 (0.39) | — | |
| SCHEMBL4070966 | 0.76 | — | — | |
| SCHEMBL9569864 | 0.75 | TRPA1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 373 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | claimed |
| EP-4471010-B1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INT BV (NL) | 2025-06-04 | — | — | EP | claimed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | claimed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | claimed |
| CN-119059951-A | Process for preparing peroxyesters or peroxycarbonates | 诺力昂化学品国际有限公司 | 2024-12-03 | — | — | CN | claimed |
| EP-1879867-A2 | INTERMEDIATES FOR PREPARING SOLIFENACIN | Teva Pharmaceutical Industries Ltd (IL) | 2008-01-23 | — | — | EP | claimed |
| EP-1315729-B1 | COMPOUNDS IN THE FORM OF HOMODIMERIC OR HETERODIMERIC PRODRUGS; PROCESS FOR OBTAINING THESE PRODRUGS AND THEIR ACCEPTABLE PHARMACEUTICAL SALTS AND USE OF COMPOUNDS IN THE TREATMENT OF PHOSPHODIESTERASES-MEDIATED DISEASES OR DYSFUNCTION | CRISTALIA PROD QUIMICOS FARM (BR) | 2008-01-09 | — | — | EP | claimed |
| WO-2007076116-A2 | INTERMEDIATES FOR PREPARING SOLIFENACIN | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-07-05 | — | — | WO | claimed |
| EP-1315729-A4 | COMPOUNDS IN THE FORM OF HOMODIMERIC, HETERODIMERIC AND/OR HOMO AND HETEROMULTIMERIC PRO-DRUGS; PROCESS FOR OBTAINING THESE PRO-DRUGS AND THEIR ACCEPTABLE PHARMACEUTICAL SALTS AND USE OF COMPOUNDS IN THE TREATMENT OF PHOSPHODIESTERASIS-MEDIATED DISEASES OR DYSFUNCTION | CRISTALIA PRODUTOS QUIMICOS E (BR) | 2004-07-07 | — | — | EP | claimed |
| US-20040106629-A1 | Compouds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated deseases or dysfunction | PACHECO, OGARI (BR) | 2004-06-03 | — | — | US | claimed |
| EP-1315729-A1 | COMPOUNDS IN THE FORM OF HOMODIMERIC, HETERODIMERIC AND/OR HOMO AND HETEROMULTIMERIC PRO-DRUGS; PROCESS FOR OBTAINING THESE PRO-DRUGS AND THEIR ACCEPTABLE PHARMACEUTICAL SALTS AND USE OF COMPOUNDS IN THE TREATMENT OF PHOSPHODIESTERASIS-MEDIATED DISEASES OR DYSFUNCTION | Cristalia Produtos Quimicos e Farmaceuticos Ltda (BR) | 2003-06-04 | — | — | EP | claimed |
| WO-2002012241-A1 | COMPOUNDS IN THE FORM OF HOMODIMERIC, HETERODIMERIC AND/OR HOMO AND HETEROMULTIMERIC PRO-DRUGS; PROCESS FOR OBTAINING THESE PRO-DRUGS AND THEIR ACCEPTABLE PHARMACEUTICAL SALTS AND USE OF COMPOUNDS IN THE TREATMENT OF PHOSPHODIESTERASIS-MEDIATED DISEASES OR DYSFUNCTION | Cristália Produtos Químicos e Farmacêuticos Ltda. (BR) | 2002-02-14 | — | — | WO | claimed |
| EP-0362141-B1 | Electrically conductive support and polymer films, and process for manufacturing the same | CIBA GEIGY AG (CH) | 1995-11-15 | — | — | EP | claimed |
| EP-0362143-B1 | Antistatic and electrically conductive relief images, process for manufacturing the same, coating material and radiation-sensitive polymers | CIBA GEIGY AG (CH) | 1995-11-15 | — | — | EP | claimed |
| EP-0521826-B1 | Process for the production of electroconductive layers | CIBA GEIGY AG (CH) | 1995-06-07 | — | — | EP | claimed |
| US-5348762-A | Process for the production of conductive layers | CIBA-GEIGY CORPORATION (US) | 1994-09-20 | — | — | US | claimed |
| EP-0285564-B1 | ANTISTATIC AND ELECTRICALLY CONDUCTIVE POLYMERS AND MOULDING COMPOSITIONS | CIBA-GEIGY AG (CH) | 1992-04-15 | — | — | EP | claimed |
| US-5096780-A | ELECTRICALLY CONDUCTIVE COATING COMPRISING A NEEDLE NETWORK OF CHANGE TRANSFER COMPLEXES | CIBA-GEIGY CORPORATION (US) | 1992-03-17 | — | — | US | claimed |
| US-5009812-A | Forming charge transfer complexes | CIBA-GEIGY CORPORATION (US) | 1991-04-23 | — | — | US | claimed |
| US-12577197-B2 | Methods of preparing N6-((2-azidoethoxy)carbonyl)lysine | SANOFI (FR) | 2026-03-17 | — | — | US | disclosed |
| US-12473251-B2 | Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-11-18 | — | — | US | disclosed |
| US-12466821-B2 | Antiviral pyridopyrazinedione compounds | NOVARTIS AG (CH) | 2025-11-11 | — | — | US | disclosed |
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | disclosed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | disclosed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | disclosed |
| CN-119059951-A | Process for preparing peroxyesters or peroxycarbonates | 诺力昂化学品国际有限公司 | 2024-12-03 | — | — | CN | disclosed |
| US-11944618-B2 | Subcutaneous delivery of polymer conjugates of therapeutic agents | SERINA THERAPEUTICS, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| WO-2023173084-A9 | CYCLOPEPTIBODIES AND USES THEREOF | UNIVERSITY OF ROCHESTER (US) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023173084-A1 | CYCLOPEPTIBODIES AND USES THEREOF | UNIVERSITY OF ROCHESTER (US) | 2023-09-14 | — | — | WO | disclosed |
| US-20230192594-A1 | CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE | UNIVERSITY OF MARYLAND, BALTIMORE | 2023-06-22 | — | — | US | disclosed |
| US-20230159581-A1 | NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS | SYNOVO GMBH (DE) | 2023-05-25 | — | — | US | disclosed |
| US-20230131943-A1 | ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONS | BURNET MICHEAL W (DE) | 2023-04-27 | — | — | US | disclosed |
| US-11613514-B2 | Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-03-28 | — | — | US | disclosed |
| US-20230052629-A1 | ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 2023-02-16 | — | — | US | disclosed |
| EP-4122945-A1 | METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES | University of Rochester (US) | 2023-01-25 | — | — | EP | disclosed |
| US-20220354841-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS, INC. (US) | 2022-11-10 | — | — | US | disclosed |
| US-20220324792-A1 | METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE | Synthorx, Inc. (US) | 2022-10-13 | — | — | US | disclosed |
| CN-115108927-A | Crystal forms and synthesis methods of (2R,6R) -hydroxynorketamine and (2S,6S) -hydroxynorketamine | 美国政府健康及人类服务部 | 2022-09-27 | — | — | CN | disclosed |
| CN-115087634-A | Method for preparing N6- ((2-azidoethoxy) carbonyl) lysine | 新索思股份有限公司 | 2022-09-20 | — | — | CN | disclosed |
| US-11420995-B2 | Anti-infective and anti-inflammatory compounds | SYNOVO GMBH (DE) | 2022-08-23 | — | — | US | disclosed |
| CN-109311801-B | Crystal forms and synthesis methods of (2R,6R) -hydroxynorketamine and (2S,6S) -hydroxynorketamine | 美国政府健康及人类服务部 | 2022-07-26 | — | — | CN | disclosed |
| EP-3788054-B1 | PHOSPHOLIDINES THAT ARE BCL FAMILY ANTAGONISTS FOR USE IN CLINICAL MANAGEMENT OF CONDITIONS CAUSED OR MEDIATED BY SENESCENT CELLS AND FOR TREATING CANCER | UNITY BIOTECHNOLOGY INC (US) | 2022-07-20 | — | — | EP | disclosed |
| EP-3087088-B1 | METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES | UNIV ROCHESTER (US) | 2022-05-25 | — | — | EP | disclosed |
| US-11298350-B2 | Subcutaneous delivery of polymer conjugates of therapeutics agents | SERINA THERAPEUTICS, INC. (US) | 2022-04-12 | — | — | US | disclosed |
| CN-110327848-B | Device for phosgenation reaction and production process of phosgenation reaction | 江苏蓝丰生物化工股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| US-11224595-B2 | Subcutaneous delivery of poly(oxazoline) polymer conjugates | SERINA THERAPEUTICS, INC. (US) | 2022-01-18 | — | — | US | disclosed |
| CN-110662752-B | Bcl family antagonist phosphoheterocyclic compounds for the clinical management of conditions caused or mediated by senescent cells and the treatment of cancer | 尤尼蒂生物技术公司 | 2022-01-14 | — | — | CN | disclosed |
| CN-111233789-B | 2-piperazine ethyl phenyl carbamate derivatives and pharmaceutical application thereof | 南京缘聚医药科技有限公司 | 2021-09-03 | — | — | CN | disclosed |
| US-11072610-B2 | Antiviral pyridopyrazinedione compounds | NOVARTIS AG (CH) | 2021-07-27 | — | — | US | disclosed |
| EP-3849979-A1 | ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS | Novartis AG (CH) | 2021-07-21 | — | — | EP | disclosed |
| WO-2021133839-A1 | METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE | Synthorx, Inc. (US) | 2021-07-01 | — | — | WO | disclosed |
| CN-112996789-A | Antiviral pyridopyrazinedione compounds | 诺华股份有限公司 | 2021-06-18 | — | — | CN | disclosed |
| US-20210139411-A1 | CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-05-13 | — | — | US | disclosed |
| US-20210070788-A1 | Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer | UNITY BIOTECHNOLOGY, INC. | 2021-03-11 | — | — | US | disclosed |
| US-20210070788-A1 | Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer | UNITY BIOTECHNOLOGY, INC. | 2021-03-11 | — | — | US | disclosed |
| EP-3788054-A1 | PHOSPHOLIDINES THAT ARE BCL FAMILY ANTAGONISTS FOR USE IN CLINICAL MANAGEMENT OF CONDITIONS CAUSED OR MEDIATED BY SENESCENT CELLS AND FOR TREATING CANCER | Unity Biotechnology (US) | 2021-03-10 | — | — | EP | disclosed |
| US-10919842-B2 | Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2021-02-16 | — | — | US | disclosed |
| WO-2020242218-A1 | GLUTATHIONE PRECURSOR DRUG-DELIVERY CARRIER COMPRISING GLUTATHIONE-S-TRANSFERASE AND PROTEIN, WHICH HAS BINDING CAPACITY FOR TARGET CELL OR TARGET PROTEIN, AND USE THEREOF | 울산과학기술원 | 2020-12-03 | — | — | WO | disclosed |
| US-20200299675-A1 | Methods and Compositions for Display of Macrocyclic Peptides | UNIVERSITY OF ROCHESTER | 2020-09-24 | — | — | US | disclosed |
| US-20200262857-A1 | NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS | SYNOVO GMBH (DE) | 2020-08-20 | — | — | US | disclosed |
| US-10745429-B2 | Phospholidines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer | UNITY BIOTECHNOLOGY, INC. (US) | 2020-08-18 | — | — | US | disclosed |
| CN-111233789-A | 2-piperazine ethyl phenyl carbamate derivatives and pharmaceutical application thereof | 南京缘聚医药科技有限公司 | 2020-06-05 | — | — | CN | disclosed |
| US-20200093816-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTICS AGENTS | SERINA THERAPEUTICS (AL), INC. | 2020-03-26 | — | — | US | disclosed |
| WO-2020053654-A1 | ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS | NOVARTIS AG (CH) | 2020-03-19 | — | — | WO | disclosed |
| US-20200079772-A1 | ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS | NOVARTIS AG (CH) | 2020-03-12 | — | — | US | disclosed |
| US-10544191-B2 | Methods and compositions for ribosomal synthesis of macrocyclic peptides | UNIVERSITY OF ROCHESTER (US) | 2020-01-28 | — | — | US | disclosed |
| CN-110662752-A | Bcl family antagonist phosphoheterocyclic compounds for the clinical management of conditions caused or mediated by senescent cells and the treatment of cancer | 尤尼蒂生物技术公司 | 2020-01-07 | — | — | CN | disclosed |
| US-20190330250-A1 | Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating Cancer | UNITY BIOTECHNOLOGY, INC. | 2019-10-31 | — | — | US | disclosed |
| US-20190330250-A1 | Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating Cancer | UNITY BIOTECHNOLOGY, INC. | 2019-10-31 | — | — | US | disclosed |
| EP-2773379-B1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS INC (US) | 2019-10-09 | — | — | EP | disclosed |
| US-10426768-B2 | Subcutaneous delivery of polymer conjugates of therapeutic agents | Sarina Therapeutics, Inc. (US) | 2019-10-01 | — | — | US | disclosed |
| US-20190290638-A1 | SUBCUTANEOUS DELIVERY OF POLY(OXAZOLINE) POLYMER CONJUGATES | SERINA THERAPEUTICS (AL), INC. | 2019-09-26 | — | — | US | disclosed |
| US-10314837-B2 | Subcutaneous delivery of poly(oxazoline) polymer conjugates | SERINA THERAPEUTICS, INC. (US) | 2019-06-11 | — | — | US | disclosed |
| US-20190135732-A1 | CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-05-09 | — | — | US | disclosed |
| EP-3433230-A1 | CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) | 2019-01-30 | — | — | EP | disclosed |
| WO-2017165878-A1 | CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2017-09-28 | — | — | WO | disclosed |
| US-9758480-B2 | 1-(cycloalkyl-carbonyl)proline derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| US-20170202972-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS (AL), INC. | 2017-07-20 | — | — | US | disclosed |
| US-20170202972-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS (AL), INC. | 2017-07-20 | — | — | US | disclosed |
| US-20170202972-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS (AL), INC. | 2017-07-20 | — | — | US | disclosed |
| US-20160355552-A1 | METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-12-08 | — | — | US | disclosed |
| EP-3087088-A2 | METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES | University Of Rochester (US) | 2016-11-02 | — | — | EP | disclosed |
| US-20160303250-A1 | Subcutaneous Delivery of Poly(oxazoline) Polymer Conjugates | SERINA THERAPEUTICS (AL), INC. | 2016-10-20 | — | — | US | disclosed |
| US-20160303250-A1 | Subcutaneous Delivery of Poly(oxazoline) Polymer Conjugates | SERINA THERAPEUTICS (AL), INC. | 2016-10-20 | — | — | US | disclosed |
| US-20160303250-A1 | Subcutaneous Delivery of Poly(oxazoline) Polymer Conjugates | SERINA THERAPEUTICS (AL), INC. | 2016-10-20 | — | — | US | disclosed |
| EP-2848613-B1 | DIAMINOARYL DERIVATIVES SUBSTITUTED BY CARBAMATE AND PESTICIDAL COMPOSITION CONTAINING SAME | KYUNG NONG CORP (KR) | 2016-09-21 | — | — | EP | disclosed |
| US-20160237059-A1 | HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-08-18 | — | — | US | disclosed |
| US-20160237059-A1 | HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-08-18 | — | — | US | disclosed |
| US-20160237059-A1 | HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-08-18 | — | — | US | disclosed |
| US-9193697-B2 | Oxazole derivatives useful as modulators of FAAH | MERCK SHARP & DOHME CORP. (US) | 2015-11-24 | — | — | US | disclosed |
| WO-2015100277-A9 | METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES | UNIVERSITY OF ROCHESTER (US) | 2015-10-01 | — | — | WO | disclosed |
| US-20150210640-A1 | 1-(CYCLOALKYL-CARBONYL)PROLINE DERIVATIVE | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2015-07-30 | — | — | US | disclosed |
| EP-2486013-B1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL MYERS SQUIBB CO (US) | 2015-07-08 | — | — | EP | disclosed |
| EP-2486013-B1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL MYERS SQUIBB CO (US) | 2015-07-08 | — | — | EP | disclosed |
| WO-2015100277-A2 | METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES | UNIVERSITY OF ROCHESTER (US) | 2015-07-02 | — | — | WO | disclosed |
| EP-2876105-A1 | 1-(CYCLOALKYL-CARBONYL)PROLINE DERIVATIVE | Sumitomo Dainippon Pharma Co., Ltd. (JP) | 2015-05-27 | — | — | EP | disclosed |
| US-9018233-B2 | Diaminoaryl derivatives substituted by carbamate and pesticidal composition containing same | KYUNG NONG CORPORATION (KR) | 2015-04-28 | — | — | US | disclosed |
| US-20150094342-A1 | DIAMINOARYL DERIVATIVES SUBSTITUTED BY CARBAMATE AND PESTICIDAL COMPOSITION CONTAINING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2015-04-02 | — | — | US | disclosed |
| WO-2015036560-A1 | HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2015-03-19 | — | — | WO | disclosed |
| EP-2848613-A1 | DIAMINOARYL DERIVATIVES SUBSTITUTED BY CARBAMATE AND PESTICIDAL COMPOSITION CONTAINING SAME | Kyung Nong Corporation (KR) | 2015-03-18 | — | — | EP | disclosed |
| US-20140271527-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140271527-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| EP-2773379-A2 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | Serina Therapeutics, Inc. (US) | 2014-09-10 | — | — | EP | disclosed |
| US-8796324-B2 | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-08-05 | — | — | US | disclosed |
| US-20140112880-A1 | SUBCUTANEOUS DELIVERY OF POLY(OXAZOLINE) POLYMER CONJUGATES | SERINA THERAPEUTICS, INC. (US) | 2014-04-24 | — | — | US | disclosed |
| US-20140112880-A1 | SUBCUTANEOUS DELIVERY OF POLY(OXAZOLINE) POLYMER CONJUGATES | SERINA THERAPEUTICS, INC. (US) | 2014-04-24 | — | — | US | disclosed |
| EP-1425262-B1 | Acylthiols and compositions thereof as anti-HIV and anti-retroviral agents | GOV OF USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES NAT INST OF HEALTH (US) | 2014-01-08 | — | — | EP | disclosed |
| EP-2391602-B1 | CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2013-12-04 | — | — | EP | disclosed |
| US-8597633-B2 | Subcutaneous delivery of poly(oxazoline) conjugates | SERINA THERAPEUTICS, INC. (US) | 2013-12-03 | — | — | US | disclosed |
| EP-1757609-B1 | NOVEL WATER-SOLUBLE PRODRUG | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2013-10-16 | — | — | EP | disclosed |
| EP-2069411-B1 | CHAIN END FUNCTIONALIZED FLUOROPOLYMERS HAVING GOOD ELECTRICAL PROPERTIES AND GOOD CHEMICAL REACTIVITY | PENN STATE RES FOUND (US) | 2013-08-28 | — | — | EP | disclosed |
| US-20130178444-A1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL MYERS SQUIBB CO (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130178444-A1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL MYERS SQUIBB CO (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130178444-A1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL MYERS SQUIBB CO (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130177521-A1 | Subcutaneous Delivery of Poly(oxazoline) Conjugates | SERINA THERAPEUTICS, INC. (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130177521-A1 | Subcutaneous Delivery of Poly(oxazoline) Conjugates | SERINA THERAPEUTICS, INC. (US) | 2013-07-11 | — | — | US | disclosed |
| WO-2013067199-A2 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS, INC. (US) | 2013-05-10 | — | — | WO | disclosed |
| US-8410139-B2 | Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-04-02 | — | — | US | disclosed |
| US-8410139-B2 | Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-04-02 | — | — | US | disclosed |
| US-8410139-B2 | Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-04-02 | — | — | US | disclosed |
| US-8383093-B1 | Subcutaneous delivery of poly(oxazoline) conjugates | SERINA THERAPEUTICS, INC. (US) | 2013-02-26 | — | — | US | disclosed |
| US-8383093-B1 | Subcutaneous delivery of poly(oxazoline) conjugates | SERINA THERAPEUTICS, INC. (US) | 2013-02-26 | — | — | US | disclosed |
| EP-2555772-A1 | OXAZOLE DERIVATIVES USEFUL AS MODULATORS OF FAAH | Merck Sharp & Dohme Corp. (US) | 2013-02-13 | — | — | EP | disclosed |
| US-8362065-B2 | Carbazole carboxamide compounds useful as kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-01-29 | — | — | US | disclosed |
| US-20130018048-A1 | OXAZOLE DERIVATIVES USEFUL AS MODULATORS OF FAAH | MERCK SHARP & DOHME CORP. (US) | 2013-01-17 | — | — | US | disclosed |
| US-20120238607-A1 | SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-09-20 | — | — | US | disclosed |
| EP-2486013-A1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Bristol-Myers Squibb Company (US) | 2012-08-15 | — | — | EP | disclosed |
| US-8168647-B2 | Vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives | SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) | 2012-05-01 | — | — | US | disclosed |
| US-8168647-B2 | Vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives | SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) | 2012-05-01 | — | — | US | disclosed |
| US-20120058984-A1 | PYRIMIDINE DERIVATIVES USED AS ITK INHIBITORS | GLAXO GROUP LIMITED (GB) | 2012-03-08 | — | — | US | disclosed |
| US-20120058996-A1 | CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2012-03-08 | — | — | US | disclosed |
| US-20120035214-A1 | RENIN INHIBITORS | MERCK CANADA INC. (CA) | 2012-02-09 | — | — | US | disclosed |
| EP-2413941-A1 | RENIN INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2012-02-08 | — | — | EP | disclosed |
| EP-2408769-A1 | PYRIMIDINE DERIVATIVES USED AS ITK INHIBITORS | Glaxo Group Limited (GB) | 2012-01-25 | — | — | EP | disclosed |
| US-8084486-B2 | Substituted arylpyrazoles | PFIZER LIMITED (GB) | 2011-12-27 | — | — | US | disclosed |
| US-8084620-B2 | Carbazole carboxamide compounds useful as kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-12-27 | — | — | US | disclosed |
| US-8076372-B2 | Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents | GOVERNMENT OF THE UNITED STATES (US) | 2011-12-13 | — | — | US | disclosed |
| EP-2391602-A1 | CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2011-12-07 | — | — | EP | disclosed |
| US-20110294792-A1 | PURINE DERIVATIVES AS KINASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2011-12-01 | — | — | US | disclosed |
| US-8058425-B2 | Purine derivatives as kinase inhibitors | ELI LILLY AND COMPANY (US) | 2011-11-15 | — | — | US | disclosed |
| WO-2011126960-A1 | OXAZOLE DERIVATIVES USEFUL AS MODULATORS OF FAAH | MERCK SHARP & DOHME CORP. (US) | 2011-10-13 | — | — | WO | disclosed |
| US-8022065-B2 | Purine derivatives as kinase inhibitors | ELI LILLY AND COMPANY (US) | 2011-09-20 | — | — | US | disclosed |
| US-8022047-B2 | Combination anticancer agents | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2011-09-20 | — | — | US | disclosed |
| US-20110207721-A1 | PURINE DERIVATIVES AS KINASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2011-08-25 | — | — | US | disclosed |
| US-20110196011-A1 | SUBSTITUTED ARYLPYRAZOLES | PFIZER LIMITED (GB) | 2011-08-11 | — | — | US | disclosed |
| EP-1259478-B1 | COVALENT DERIVATIVES OF ALKANOLAMIDES OF MONOCARBOXYLIC AND DICARBOXYLIC ACIDS FUNCTIONALLY ACTIVE ON THE CB2 CANNABINOID RECEPTOR | INNOVET ITALIA SRL (IT) | 2011-07-13 | — | — | EP | disclosed |
| EP-1730142-B1 | NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS | SCHERING CORP (US) | 2011-06-29 | — | — | EP | disclosed |
| US-7960426-B2 | Substituted arylpyrazoles | PFIZER LIMITED (GB) | 2011-06-14 | — | — | US | disclosed |
| WO-2011044309-A1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-04-14 | — | — | WO | disclosed |
| WO-2011044309-A1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-04-14 | — | — | WO | disclosed |
| CN-101291675-B | Novel anticancer concomitant drug | CHUGAI PHARMACEUTICAL CO LTD | 2011-04-13 | — | — | CN | disclosed |
| US-20110082113-A1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2011-04-07 | — | — | US | disclosed |
| US-20110082113-A1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2011-04-07 | — | — | US | disclosed |
| US-20110082113-A1 | PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2011-04-07 | — | — | US | disclosed |
| US-7910593-B2 | Water-soluble prodrugs | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7902232-B2 | Substituted arylpyrazoles | PFIZER LIMITED (GB) | 2011-03-08 | — | — | US | disclosed |
| US-7842390-B2 | Chain end functionalized fluoropolymers having good electrical properties and good chemical reactivity | THE PENN STATE RESEARCH FOUNDATION (US) | 2010-11-30 | — | — | US | disclosed |
| WO-2010114978-A1 | RENIN INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2010-10-07 | — | — | WO | disclosed |
| WO-2010106016-A1 | PYRIMIDINE DERIVATIVES USED AS ITK INHIBITORS | GLAXO GROUP LIMITED (GB) | 2010-09-23 | — | — | WO | disclosed |
| US-7795267-B2 | Bicyclic piperazine compound having TGR23 antagonistic activity | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-09-14 | — | — | US | disclosed |
| WO-2010094721-A1 | PIPERIDIN-PYRIMIDINE DERIVATIVES AS ANTAGONISTS OF HISTAMINE H4 RECEPTOR | PALAU PHARMA, S. A. (ES) | 2010-08-26 | — | — | WO | disclosed |
| WO-2010080481-A1 | CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-07-15 | — | — | WO | disclosed |
| US-20100160303-A1 | CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2010-06-24 | — | — | US | disclosed |
| US-20100113498-A1 | NOVEL VINBLASTINE DERIVATIVES, THEIR PREPARATION, USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAID DERIVATIVES | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2010-05-06 | — | — | US | disclosed |
| US-20100113498-A1 | NOVEL VINBLASTINE DERIVATIVES, THEIR PREPARATION, USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAID DERIVATIVES | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2010-05-06 | — | — | US | disclosed |
| US-20090312371-A1 | SUBSTITUTED ARYLPYRAZOLES | PFIZER LIMITED (GB) | 2009-12-17 | — | — | US | disclosed |
| EP-2119720-A1 | NOVEL VINBLASTINE DERIVATIVES, THEIR PREPARATION, USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAID DERIVATIVES | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2009-11-18 | — | — | EP | disclosed |
| US-7619094-B2 | Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus | SCHERING CORPORATION (US) | 2009-11-17 | — | — | US | disclosed |
| US-20090247473-A1 | ACYTHIOLS AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI-RETROVIRAL AGENTS | THE GOVERNMENT OF THE U.S.A.,AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICES (US) | 2009-10-01 | — | — | US | disclosed |
| EP-0979236-B1 | APPARATUS FOR SYNTHESIS OF OLIGOMERS, ESPECIALLY PEPTOIDS, WITH REAGENT RECYCLING | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2009-07-29 | — | — | EP | disclosed |
| US-20090181966-A1 | PGD2 receptor antagonists for the treatment of inflammatory diseases | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-07-16 | — | — | US | disclosed |
| EP-2074107-A2 | TRICYCLIC COMPOUNDS AS MATRIX METALLOPROTEINASE INHIBITORS | Wyeth a Corporation of the State of Delaware (US) | 2009-07-01 | — | — | EP | disclosed |
| EP-2069411-A1 | CHAIN END FUNCTIONALIZED FLUOROPOLYMERS HAVING GOOD ELECTRICAL PROPERTIES AND GOOD CHEMICAL REACTIVITY | The Penn State Research Foundation (US) | 2009-06-17 | — | — | EP | disclosed |
| US-20090149478-A1 | NOVEL COMBINATION ANTICANCER AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA | 2009-06-11 | — | — | US | disclosed |
| US-20090137524-A1 | SUBSTITUTED ARYLPYRAZOLES | ZOETIS SERVICES LLC | 2009-05-28 | — | — | US | disclosed |
| US-20090118271-A1 | Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2009-05-07 | — | — | US | disclosed |
| US-7528274-B2 | Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2009-05-05 | — | — | US | disclosed |
| US-20090105229-A1 | PURINE DERIVATIVES AS KINASE INHIBITORS | ELI LILLY AND COMPANY | 2009-04-23 | — | — | US | disclosed |
| US-7514464-B2 | Substituted arylpyrazoles | PFIZER LIMITED (GB) | 2009-04-07 | — | — | US | disclosed |
| EP-1705989-B8 | SUBSTITUTED ARYLPYRAZOLES AS PARASITICIDAL AGENTS | PFIZER LTD (GB) | 2009-03-25 | — | — | EP | disclosed |
| EP-1501846-B1 | TRICYCLIC MACROLIDE ANTIBACTERIAL COMPOUNDS | ABBOTT LAB (US) | 2009-03-18 | — | — | EP | disclosed |
| US-7504508-B2 | PGD2 receptor antagonists for the treatment of inflammatory diseases | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-03-17 | — | — | US | disclosed |
| CN-101340913-A | Prophylactic or therapeutic agent for pancreatic cancer, ovarian cancer or liver cancer comprising novel water-soluble prodrug | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2009-01-07 | — | — | CN | disclosed |
| EP-1705989-B1 | SUBSTITUTED ARYLPYRAZOLES AS PARASITICIDAL AGENTS | PFIZER LTD (GB) | 2008-11-12 | — | — | EP | disclosed |
| CN-101291675-A | Novel anticancer concomitant drug | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2008-10-22 | — | — | CN | disclosed |
| US-7435753-B2 | Substituted arylpyrazoles | PFIZER LIMITED (GB) | 2008-10-14 | — | — | US | disclosed |
| US-20080207608-A1 | 2-Propene-1-Ones As Hsp 70 Inducers | TORRENT PHARMACEUTICALS LTD. (IN) | 2008-08-28 | — | — | US | disclosed |
| US-20080194562-A1 | Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's | ASTEX THERAPEUTICS LIMITED (GB) | 2008-08-14 | — | — | US | disclosed |
| EP-1938823-A1 | AGENT FOR PREVENTING OR TREATING PANCREAS CANCER, OVARY CANCER OR LIVER CANCER CONTAINING NOVEL WATER-SOLUBLE PRODRUG | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2008-07-02 | — | — | EP | disclosed |
| CN-101203134-A | Substituted arylpyrazoles as parasiticidal agents | PFIZER (GB) | 2008-06-18 | — | — | CN | disclosed |
| EP-1925309-A1 | NOVEL ANTICANCER CONCOMITANT DRUG | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2008-05-28 | — | — | EP | disclosed |
| WO-2008057254-A2 | TRICYCLIC COMPOUNDS AS MATRIX METALLOPROTEINASE INHIBITORS | WYETH (US) | 2008-05-15 | — | — | WO | disclosed |
| EP-1015470-A4 | COMPOSITION AND METHOD FOR DELIVERY OF NUCLEIC ACIDS | COMMW SCIENT IND RES ORG (AU) | 2008-05-07 | — | — | EP | disclosed |
| WO-2008041998-A1 | CHAIN END FUNCTIONALIZED FLUOROPOLYMERS HAVING GOOD ELECTRICAL PROPERTIES AND GOOD CHEMICAL REACTIVITY | THE PENN STATE RESEARCH FOUNDATION (US) | 2008-04-10 | — | — | WO | disclosed |
| US-20080081195-A1 | Chain end functionalized fluoropolymers having good electrical properties and good chemical reactivity | DAIKIN AMERICA, INC. | 2008-04-03 | — | — | US | disclosed |
| EP-1901608-A1 | SUBSTITUTED ARYLPYRAZOLES AS PARASITICIDAL AGENTS | Pfizer Limited (GB) | 2008-03-26 | — | — | EP | disclosed |
| US-7326699-B2 | 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives | NOVARTIS AG (CH) | 2008-02-05 | — | — | US | disclosed |
| EP-1879867-A2 | INTERMEDIATES FOR PREPARING SOLIFENACIN | Teva Pharmaceutical Industries Ltd (IL) | 2008-01-23 | — | — | EP | disclosed |
| US-20080015157-A1 | Novel Water-Soluble Prodrugs | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2008-01-17 | — | — | US | disclosed |
| EP-1315729-B1 | COMPOUNDS IN THE FORM OF HOMODIMERIC OR HETERODIMERIC PRODRUGS; PROCESS FOR OBTAINING THESE PRODRUGS AND THEIR ACCEPTABLE PHARMACEUTICAL SALTS AND USE OF COMPOUNDS IN THE TREATMENT OF PHOSPHODIESTERASES-MEDIATED DISEASES OR DYSFUNCTION | CRISTALIA PROD QUIMICOS FARM (BR) | 2008-01-09 | — | — | EP | disclosed |
| EP-1853600-A1 | PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDK'S AND GSK'S | Astex Therapeutics Limited (GB) | 2007-11-14 | — | — | EP | disclosed |
| US-20070173528-A1 | Process for preparing solifenacin | TEVA PHARMACEUTICALS USA, INC. | 2007-07-26 | — | — | US | disclosed |
| WO-2007076116-A2 | INTERMEDIATES FOR PREPARING SOLIFENACIN | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-07-05 | — | — | WO | disclosed |
| US-20070093430-A1 | Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus | MERCK SHARP & DOHME CORP. | 2007-04-26 | — | — | US | disclosed |
| US-20070072865-A1 | Bicyclic piperazine compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-03-29 | — | — | US | disclosed |
| EP-1757609-A1 | NOVEL WATER-SOLUBLE PRODRUG | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-02-28 | — | — | EP | disclosed |
| EP-1748987-A2 | 2-PROPENE-1-ONES AS HSP 70 INDUCERS | Torrent Pharmaceuticals Ltd (IN) | 2007-02-07 | — | — | EP | disclosed |
| US-7173057-B2 | Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus | SCHERING CORPORATION (US) | 2007-02-06 | — | — | US | disclosed |
| EP-1740547-A1 | PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-01-10 | — | — | EP | disclosed |
| WO-2006134466-A1 | SUBSTITUTED ARYLPYRAZOLES AS PARASITICIDAL AGENTS | PFIZER LIMITED (GB) | 2006-12-21 | — | — | WO | disclosed |
| EP-1730142-A1 | NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS | SCHERING CORPORATION (US) | 2006-12-13 | — | — | EP | disclosed |
| US-7148350-B2 | Compounds in the form of homodimeric or heterodimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterases-mediated diseases or dysfunction | CRISTALIA PROD.QUI.FARM. LTDA (BR) | 2006-12-12 | — | — | US | disclosed |
| EP-1483265-B1 | PURINE DERIVATIVES AS KINASE INHIBITORS | LILLY CO ELI (US) | 2006-11-22 | — | — | EP | disclosed |
| EP-1705989-A1 | SUBSTITUTED ARYLPYRAZOLES AS PARASITICIDAL AGENTS | Pfizer Limited (GB) | 2006-10-04 | — | — | EP | disclosed |
| US-7115767-B2 | Tetraline derivatives as ghrelin receptor modulators | ABBOTT LABORATORIES (US) | 2006-10-03 | — | — | US | disclosed |
| WO-2006077419-A1 | PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDK' S AND GSK' S | ASTEX THERAPEUTICS LIMITED (GB) | 2006-07-27 | — | — | WO | disclosed |
| CN-1264844-C | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-D) pyrimidie derivatives | NOVARTIS AG (CH) | 2006-07-19 | — | — | CN | disclosed |
| US-7078553-B2 | Dehydrohalogenation by reacting a di-hydroperoxy compound with an acid halogen or halogen formate to form mono- or di-peroxy ester or carbonate; polymerization initiators, curing agents for unsaturated polyesters and modifying agents | AKZO NOBEL N.V. (NL) | 2006-07-18 | — | — | US | disclosed |
| EP-1661898-A1 | BICYCLIC PIPERAZINE COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1425262-A4 | ACYLTHIOLS AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI-RETROVIRAL AGENTS | US GOV HEALTH & HUMAN SERV (US) | 2006-03-08 | — | — | EP | disclosed |
| US-6992069-B2 | Tricyclic macrolide antibacterial compounds | ABBVIE INC. | 2006-01-31 | — | — | US | disclosed |
| US-20060014802-A1 | Substituted arylpyrazoles | ZOETIS SERVICES LLC | 2006-01-19 | — | — | US | disclosed |
| US-20060009463-A1 | N-(3-rifamycinyl)-carbamates, method of preparing them and their use for treating and preventing tuberculosis | BALKANAPHARMA-RAZGRAD CO. (BG) | 2006-01-12 | — | — | US | disclosed |
| US-20050256158-A1 | PGD2 receptor antagonists for the treatment of inflammatory diseases | MILLENNIUM PHARMACEUTICALS, INC. | 2005-11-17 | — | — | US | disclosed |
| EP-1390369-B1 | 4-AMINO-5-PHENYL-7-CYCLOBUTYL-PYRROLO(2,3-D)PYRIMIDINE DERIVATIVES | NOVARTIS AG (CH) | 2005-11-09 | — | — | EP | disclosed |
| WO-2005100321-A1 | PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2005-10-27 | — | — | WO | disclosed |
| WO-2005097746-A2 | 2-PROPENE-1-ONES AS HSP 70 INDUCERS | TORRENT PHARMACEUTICALS LTD (IN) | 2005-10-20 | — | — | WO | disclosed |
| US-20050222047-A1 | Novel ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus | SCHERING CORPORATION | 2005-10-06 | — | — | US | disclosed |
| WO-2005085242-A1 | NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS | SCHERING CORPORATION (US) | 2005-09-15 | — | — | WO | disclosed |
| US-20050148649-A1 | Substituted arylpyrazoles | ZOETIS SERVICES LLC | 2005-07-07 | — | — | US | disclosed |
| WO-2005060749-A1 | SUBSTITUTED ARYLPYRAZOLES AS PARASITICIDAL AGENTS | PFIZER LIMITED (GB) | 2005-07-07 | — | — | WO | disclosed |
| US-20050119341-A1 | 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these | UBE INDUSTRIES, LTD. (JP) | 2005-06-02 | — | — | US | disclosed |
| US-6864285-B1 | Hypotensive agents; antihistamines; immunology moderators; antiinflammatory agents | INNOVET ITALIA S.R.L. (IT) | 2005-03-08 | — | — | US | disclosed |
| EP-1503761-A1 | SUBSTITUTED PIPERAZINES AS MELANOCORTIN RECEPTOR LIGANDS | Neurocrine Biosciences, Inc. (US) | 2005-02-09 | — | — | EP | disclosed |
| EP-1501846-A1 | TRICYCLIC MACROLIDE ANTIBACTERIAL COMPOUNDS | Abbott Laboratories (US) | 2005-02-02 | — | — | EP | disclosed |
| US-20050020831-A1 | Acylthiols and component thiol compositions as anti-hiv and anti-retroviral agents | GOVERNMENT OF THE UNITED STATES | 2005-01-27 | — | — | US | disclosed |
| EP-1500642-A1 | 3-SUBSTITUTED OXYGLUTARIC DIESTER COMPOUND, OPTICALLY ACTIVE 3-SUBSTITUTED OXYGLUTARIC MONOESTER COMPOUND, AND PROCESSES FOR PRODUCING THESE | Ube Industries, Ltd. (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-20050014794-A1 | Tetraline derivatives as ghrelin receptor modulators | ABBVIE INC. | 2005-01-20 | — | — | US | disclosed |
| EP-0777492-B1 | COMBINATORIAL LIBRARIES OF SUBSTRATE-BOUND CYCLIC ORGANIC COMPOUNDS | CHIRON CORP (US) | 2005-01-19 | — | — | EP | disclosed |
| US-20050004118-A1 | Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds | JILANI JAMAL A (JO) | 2005-01-06 | — | — | US | disclosed |
| EP-1492798-A1 | N-(3-RIFAMYCINYL)-CARBAMATES, METHOD OF PREPARING THEM AND THEIR USE FOR TREATING AND PREVENTING TUBERCULOSIS | UNIVERSITY OF LEICESTER (GB) | 2005-01-05 | — | — | EP | disclosed |
| US-20040260111-A1 | Dehydrohalogenation by reacting a di-hydroperoxy compound with an acid halogen or halogen formate to form mono- or di-peroxy ester or carbonate; polymerization initiators, curing agents for unsaturated polyesters and modifying agents | VAN DE BOVENKAMP-BOUWMAN ANNA (NL) | 2004-12-23 | — | — | US | disclosed |
| EP-1483265-A1 | PURINE DERIVATIVES AS KINASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2004-12-08 | — | — | EP | disclosed |
| CN-1531538-A | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-D) pyrimidie derivatives | ��˹��ŵ�� | 2004-09-22 | — | — | CN | disclosed |
| US-20040180911-A1 | 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives | NOVARTIS AG (CH) | 2004-09-16 | — | — | US | disclosed |
| EP-1071662-B1 | PEROXIDES, THEIR PREPARATION PROCESS AND USE | AKZO NOBEL NV (NL) | 2004-08-04 | — | — | EP | disclosed |
| US-6770774-B2 | USING A PEROXY COMPOUND AS CURING AGENT, POLYMERIZATION CATALYST | AKZO NOBEL N.V. (NL) | 2004-08-03 | — | — | US | disclosed |
| US-6765015-B2 | ANTICARCINOGENIC/ANTITUMOR AGENTS SUCH AS N-(2?-BROMO-3? METHYL)-BUTANOYL-N-DEBENZOYL-CEPHALOMANNINE | XECHEM INTERNATIONAL, INC. | 2004-07-20 | — | — | US | disclosed |
| EP-1315729-A4 | COMPOUNDS IN THE FORM OF HOMODIMERIC, HETERODIMERIC AND/OR HOMO AND HETEROMULTIMERIC PRO-DRUGS; PROCESS FOR OBTAINING THESE PRO-DRUGS AND THEIR ACCEPTABLE PHARMACEUTICAL SALTS AND USE OF COMPOUNDS IN THE TREATMENT OF PHOSPHODIESTERASIS-MEDIATED DISEASES OR DYSFUNCTION | CRISTALIA PRODUTOS QUIMICOS E (BR) | 2004-07-07 | — | — | EP | disclosed |
| EP-1311268-A4 | IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE ANTIVIRAL AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2004-06-30 | — | — | EP | disclosed |
| EP-1425262-A1 | ACYLTHIOLS AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI-RETROVIRAL AGENTS | The Gov. of USA, as represented by the Secretary, Dept. of Health and Human services, National Institutes of Health (US) | 2004-06-09 | — | — | EP | disclosed |
| US-20040106629-A1 | Compouds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated deseases or dysfunction | PACHECO, OGARI (BR) | 2004-06-03 | — | — | US | disclosed |
| US-20040063783-A1 | Nitroso diphenylamine derivatives | MERCK PATENT GMBH (DE) | 2004-04-01 | — | — | US | disclosed |
| US-20040053933-A1 | Ligands of melanocortin receptors and compositions and methods related thereto | NEUROCRINE BIOSCIENCES, INC. | 2004-03-18 | — | — | US | disclosed |
| EP-1390369-A1 | 4-AMINO-5-PHENYL-7-CYCLOBUTYL-PYRROLO(2,3-D)PYRIMIDINE DERIVATIVES | Novartis AG (CH) | 2004-02-25 | — | — | EP | disclosed |
| US-20040029818-A1 | Tricyclic macrolide antibacterial compounds | ABBVIE INC. | 2004-02-12 | — | — | US | disclosed |
| US-20030220338-A1 | Fungal efflux pump inhibitors | ESSENTIAL THERAPEUTICS, INC. | 2003-11-27 | — | — | US | disclosed |
| WO-2003094918-A1 | SUBSTITUTED PIPERAZINE AS MELANOCORTIN RECEPTORS LIGANDS | NEUROCRINE BIOSCIENCES, INC. (US) | 2003-11-20 | — | — | WO | disclosed |
| WO-2003093289-A1 | TRICYCLIC MACROLIDE ANTIBACTERIAL COMPOUNDS | ABBOTT LABORATORIES (US) | 2003-11-13 | — | — | WO | disclosed |
| WO-2003084965-A1 | N-(3-RIFAMYCINYL)-CARBAMATES, METHOD OF PREPARING THEM AND THEIR USE FOR TREATING AND PREVENTING TUBERCULOSIS | UFZ-UMWELTFORSCHUNGSZENTRUM LEIPZIG-HALLE GMBH (DE) | 2003-10-16 | — | — | WO | disclosed |
| WO-2003076442-A1 | PURINE DERIVATIVES AS KINASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2003-09-18 | — | — | WO | disclosed |
| EP-0928791-B1 | PROCESS FOR PRODUCING 1,4-BENZODIOXANE DERIVATIVES | DAISO CO LTD (JP) | 2003-07-30 | — | — | EP | disclosed |
| EP-1322598-A1 | NITROSO DIPHENYLAMINE DERIVATIVES | MERCK PATENT GmbH (DE) | 2003-07-02 | — | — | EP | disclosed |
| EP-1028721-B1 | N,N'-BIS(SULFONYL)HYDRAZINES USEFUL AS ANTINEOPLASTIC AGENTS | UNIV YALE (US) | 2003-06-04 | — | — | EP | disclosed |
| EP-1315729-A1 | COMPOUNDS IN THE FORM OF HOMODIMERIC, HETERODIMERIC AND/OR HOMO AND HETEROMULTIMERIC PRO-DRUGS; PROCESS FOR OBTAINING THESE PRO-DRUGS AND THEIR ACCEPTABLE PHARMACEUTICAL SALTS AND USE OF COMPOUNDS IN THE TREATMENT OF PHOSPHODIESTERASIS-MEDIATED DISEASES OR DYSFUNCTION | Cristalia Produtos Quimicos e Farmaceuticos Ltda (BR) | 2003-06-04 | — | — | EP | disclosed |
| EP-1311268-A1 | IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE ANTIVIRAL AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-05-21 | — | — | EP | disclosed |
| EP-0993442-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-04-23 | — | — | EP | disclosed |
| US-6552215-B1 | Reacting a hydroperoxy compound containing a peroxyester or peroxycarbonate functionality with an alkyl vinyl ether; polymerization initiators, curing agents for unsaturated polyesters and modifying agents | AKZO NOBEL N.V. (NL) | 2003-04-22 | — | — | US | disclosed |
| US-20030073861-A1 | Using a peroxy compound as curing agent, polymerization catalyst | VAN DE BOVENKAMP-BOUWMAN ANNA (NL) | 2003-04-17 | — | — | US | disclosed |
| US-20030060465-A1 | Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds | SPECIALIZED PHARMACEUTICAL RESEARCH LTD. CO. (JO) | 2003-03-27 | — | — | US | disclosed |
| EP-1049668-B1 | KETONE PEROXIDE DERIVATIVES, THEIR PREPARATION AND USE | AKZO NOBEL NV (NL) | 2003-03-19 | — | — | EP | disclosed |
| EP-0789577-B1 | SYNTHESIS OF N-SUBSTITUTED OLIGOMERS | CHIRON CORP (US) | 2003-03-12 | — | — | EP | disclosed |
| EP-1105118-A4 | HALOGENATED PACLITAXEL DERIVATIVES | XECHEM INC (US) | 2003-02-26 | — | — | EP | disclosed |
| WO-2003014062-A1 | ACYLTHIOLS AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI-RETROVIRAL AGENTS | THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2003-02-20 | — | — | WO | disclosed |
| US-6489338-B2 | TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. | BRISTOL-MYERS SQUIBB COMPANY | 2002-12-03 | — | — | US | disclosed |
| EP-0671928-B1 | SYNTHESIS OF N-SUBSTITUTED OLIGOMERS | CHIRON CORP (US) | 2002-11-27 | — | — | EP | disclosed |
| EP-1259478-A1 | COVALENT DERIVATIVES OF ALKANOLAMIDES OF MONOCARBOXYLIC AND DICARBOXYLIC ACIDS FUNCTIONALLY ACTIVE ON THE CB2 CANNABINOID RECEPTOR | Innovet Italia S.r.l. (IT) | 2002-11-27 | — | — | EP | disclosed |
| EP-0777492-A4 | COMBINATORIAL LIBRARIES OF SUBSTRATE-BOUND CYCLIC ORGANIC COMPOUNDS | CHIRON CORP (US) | 2002-11-27 | — | — | EP | disclosed |
| WO-2002092599-A1 | 4-AMINO-5-PHENYL-7-CYCLOBUTYL-PYRROLO (2,3-D) PYRIMIDINE DERIVATIVES | NOVARTIS AG (CH) | 2002-11-21 | — | — | WO | disclosed |
| EP-1258492-A1 | N-substituted oligomers and methods for their synthesis, e.g. polyglycine bearing nucleic acid bases | CHIRON CORPORATION (US) | 2002-11-20 | — | — | EP | disclosed |
| US-6482970-B1 | Peroxides, their preparation process and use | AKZO NOBEL NV (NL) | 2002-11-19 | — | — | US | disclosed |
| EP-1231209-A1 | Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compound | Specialized Pharmaceutical Research Ltd. Co. (JO) | 2002-08-14 | — | — | EP | disclosed |
| US-20020107409-A1 | Halogenated paclitaxel derivatives | XECHEM, INC. | 2002-08-08 | — | — | US | disclosed |
| WO-2002028820-A1 | NITROSO DIPHENYLAMINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2002-04-11 | — | — | WO | disclosed |
| US-6369057-B1 | VIRICIDES, IN PARTICULAR AGAINST RETROVIRUSES, HUMAN IMMUNODEFICIENCY VIRUS (HIV) | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-04-09 | — | — | US | disclosed |
| WO-2002012241-A1 | COMPOUNDS IN THE FORM OF HOMODIMERIC, HETERODIMERIC AND/OR HOMO AND HETEROMULTIMERIC PRO-DRUGS; PROCESS FOR OBTAINING THESE PRO-DRUGS AND THEIR ACCEPTABLE PHARMACEUTICAL SALTS AND USE OF COMPOUNDS IN THE TREATMENT OF PHOSPHODIESTERASIS-MEDIATED DISEASES OR DYSFUNCTION | Cristália Produtos Químicos e Farmacêuticos Ltda. (BR) | 2002-02-14 | — | — | WO | disclosed |
| US-20020016309-A1 | Imidazopyridine and imidazopyrimidine antiviral agents | BRISTOL-MEYERS SQUIBB COMPANY | 2002-02-07 | — | — | US | disclosed |
| WO-2001095910-A1 | IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE ANTIVIRAL AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |
| EP-1105118-A1 | HALOGENATED PACLITAXEL DERIVATIVES | Xechem, Inc. (US) | 2001-06-13 | — | — | EP | disclosed |
| US-6235787-B1 | ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS | HOFFMANN-LA ROCHE INC. | 2001-05-22 | — | — | US | disclosed |
| EP-0923621-B1 | MONOAZO DYES SUBSTITUTED BY HALOALKYLCARBAMATE AND SULPHONYLFLUORIDE GROUPS | DYSTAR TEXTILFARBEN GMBH & CO (DE) | 2001-05-16 | — | — | EP | disclosed |
| EP-1028721-A4 | N,N'-BIS(SULFONYL)HYDRAZINES USEFUL AS ANTINEOPLASTIC AGENTS | UNIV YALE (US) | 2001-01-31 | — | — | EP | disclosed |
| EP-1071662-A1 | PEROXIDES, THEIR PREPARATION PROCESS AND USE | Akzo Nobel N.V. (NL) | 2001-01-31 | — | — | EP | disclosed |
| WO-2001004083-A1 | COVALENT DERIVATIVES OF ALKANOLAMIDES OF MONOCARBOXYLIC AND DICARBOXYLIC ACIDS FUNCTIONALLY ACTIVE ON THE CB2 CANNABINOID RECEPTOR | INNOVET ITALIA S.R.L. (IT) | 2001-01-18 | — | — | WO | disclosed |
| US-6166236-A | Vinyl carbonate and vinyl carbamate contact lens material monomers | BAUSCH & LOMB INCORPORATED (US) | 2000-12-26 | — | — | US | disclosed |
| EP-1049668-A1 | KETONE PEROXIDE DERIVATIVES, THEIR PREPARATION AND USE | Akzo Nobel N.V. (NL) | 2000-11-08 | — | — | EP | disclosed |
| EP-1028721-A1 | $i(N,N')-BIS(SULFONYL)HYDRAZINES USEFUL AS ANTINEOPLASTIC AGENTS | Yale University (US) | 2000-08-23 | — | — | EP | disclosed |
| EP-1015470-A1 | COMPOSITION AND METHOD FOR DELIVERY OF NUCLEIC ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-07-05 | — | — | EP | disclosed |
| EP-0993442-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-04-19 | — | — | EP | disclosed |
| US-6040338-A | N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents | YALE UNIVERSITY (US) | 2000-03-21 | — | — | US | disclosed |
| US-6033631-A | Synthesizer with reagent recycling | CHIRON CORPORATION (US) | 2000-03-07 | — | — | US | disclosed |
| EP-0979236-A1 | APPARATUS FOR SYNTHESIS OF OLIGOMERS, ESPECIALLY PEPTOIDS, WITH REAGENT RECYCLING | CHIRON CORPORATION (US) | 2000-02-16 | — | — | EP | disclosed |
| US-6020503-A | Process for producing 1,4-benzodioxane derivatives | DAISO CO., LTD. (JP) | 2000-02-01 | — | — | US | disclosed |
| US-5977301-A | AUTOMATED AND EFFICIENT SYNTHESIS BY REACTING SOLID SUPPORT BOUND AMINE WITH AN ACYLATING SUBMONOMER TO PRODUCE A SOLID SUPPORT-BOUND AMIDE WHICH CAN BE FURTHER REACTED; ONLY REACTIVE SIDE CHAINS NEED PROTECTED | CHIRON CORPORATION (US) | 1999-11-02 | — | — | US | disclosed |
| US-5973127-A | WATER INSOLUBILITY; COLORING SYNTHETIC TEXTILE FABRICS | BASF AKTIENGESELLSCHAFT (DE) | 1999-10-26 | — | — | US | disclosed |
| WO-1999052864-A1 | PEROXIDES, THEIR PREPARATION PROCESS AND USE | AKZO NOBEL N.V. (NL) | 1999-10-21 | — | — | WO | disclosed |
| US-5958792-A | DERIVATIZING SOLID SUPPORT SURFACES WITH A GROUP CONSISTING OF O AND NH TO PROVIDE PLURALITY OF DERIVATIZED SUPPORT SURFACES, DIVIDING THEM INTO SUBAMOUNTS, REACTING DIFFERENT SUBMONOMER WITH ACTIVE GROUP OF SUBAMOUNT, RECOMBINING | CHIRON CORPORATION (US) | 1999-09-28 | — | — | US | disclosed |
| US-5942387-A | Combinatorial process for preparing substituted thiophene libraries | ELI LILLY AND COMPANY (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0928791-A1 | PROCESS FOR PRODUCING 1,4-BENZODIOXANE DERIVATIVES | DAISO CO., LTD. (JP) | 1999-07-14 | — | — | EP | disclosed |
| WO-1999032442-A1 | KETONE PEROXIDE DERIVATIVES, THEIR PREPARATION AND USE | AKZO NOBEL N.V. (NL) | 1999-07-01 | — | — | WO | disclosed |
| EP-0923621-A1 | MONOAZO DYES SUBSTITUTED BY HALOALKYLCARBAMATE AND SULPHONYLFLUORIDE GROUPS | BASF AKTIENGESELLSCHAFT (DE) | 1999-06-23 | — | — | EP | disclosed |
| US-5908919-A | DRUG DELIVERY | TERRAPIN TECHNOLOGIES (US) | 1999-06-01 | — | — | US | disclosed |
| WO-1999025334-A1 | HALOGENATED PACLITAXEL DERIVATIVES | XECHEM INTERNATIONAL, INC. (US) | 1999-05-27 | — | — | WO | disclosed |
| WO-1999022726-A1 | N,N'-BIS(SULFONYL)HYDRAZINES USEFUL AS ANTINEOPLASTIC AGENTS | YALE UNIVERSITY (US) | 1999-05-14 | — | — | WO | disclosed |
| US-5877278-A | SOLID PHASE SYNTHESIS USING TWO SUBMONOMERS-AN ACYLATING AGENT, E.G. A HALOACETIC ACID, AND A PRIMARY AMINE; CYCLIZATION TO PRODUCE MIMETICS OF DRUGS; ELIMINATION OF THE NECESSITY OF PROTECTION GROUPS | CHIRON CORPORATION (US) | 1999-03-02 | — | — | US | disclosed |
| WO-1999001428-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-01-14 | — | — | WO | disclosed |
| US-5854224-A | Composition and method for delivery of nucleic acids | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-12-29 | — | — | US | disclosed |
| WO-1997049770-A9 | MONOAZO DYES SUBSTITUTED BY HALOALKYLCARBAMATE AND SULPHONYLFLUORIDE GROUPS | — | 1998-12-23 | — | — | WO | disclosed |
| WO-1998049187-A1 | APPARATUS FOR SYNTHESIS OF OLIGOMERS, ESPECIALLY PEPTOIDS, WITH REAGENT RECYCLING | CHIRON CORPORATION (US) | 1998-11-05 | — | — | WO | disclosed |
| US-5831005-A | ACYLATION, NUCLEOPHILIC DISPLACEMENT CYCLES | CHIRON CORPORATION (US) | 1998-11-03 | — | — | US | disclosed |
| CN-1192154-A | Combinatorial libraries of substrate-bound cyclic organic compounds | CHIRON CORP (US) | 1998-09-02 | — | — | CN | disclosed |
| EP-0789577-A4 | SYNTHESIS OF N-SUBSTITUTED OLIGOMERS | CHIRON CORP (US) | 1998-07-22 | — | — | EP | disclosed |
| US-5747458-A | PLASMINOGEN ACTIVATOR OF PROTEASE AND TRIPEPTIDES | CHIRON CORPORATION (US) | 1998-05-05 | — | — | US | disclosed |
| EP-0832101-A2 | URETHANE MEDIATED, GST SPECIFIC MOLECULAR RELEASE SYSTEMS | TERRAPIN TECHNOLOGIES, INC. (US) | 1998-04-01 | — | — | EP | disclosed |
| EP-0825164-A2 | Scavenger assisted combinatorial process for preparing libraries of amides, carbamates and sulfonamides | ELI LILLY AND COMPANY (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1997049770-A1 | MONOAZO DYES SUBSTITUTED BY HALOALKYLCARBAMATE AND SULPHONYLFLUORIDE GROUPS | BASF AKTIENGESELLSCHAFT (DE) | 1997-12-31 | — | — | WO | disclosed |
| EP-0800513-A1 | OPIATE RECEPTOR LIGANDS | CHIRON CORPORATION (US) | 1997-10-15 | — | — | EP | disclosed |
| EP-0789577-A1 | SYNTHESIS OF N-SUBSTITUTED OLIGOMERS | CHIRON CORPORATION (US) | 1997-08-20 | — | — | EP | disclosed |
| WO-1997025339-A1 | COMPOSITION AND METHOD FOR DELIVERY OF NUCLEIC ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1997-07-17 | — | — | WO | disclosed |
| EP-0396364-B1 | Copolymers of vinyl carbonate and vinyl carbamate as contact lens material | BAUSCH & LOMB (US) | 1997-06-11 | — | — | EP | disclosed |
| EP-0777492-A1 | COMBINATORIAL LIBRARIES OF SUBSTRATE-BOUND CYCLIC ORGANIC COMPOUNDS | CHIRON CORPORATION (US) | 1997-06-11 | — | — | EP | disclosed |
| EP-0671928-A4 | SYNTHESIS OF N-SUBSTITUTED OLIGOMERS. | CHIRON CORP (US) | 1997-04-23 | — | — | EP | disclosed |
| US-5622944-A | MODIFIED 17-HYDROXY STEROL; TRANSDERMAL ELECTROTRANSPORT ENHANCEMENT | AFFYMAX TECHNOLOGIES N.V. (GB) | 1997-04-22 | — | — | US | disclosed |
| EP-0669923-B1 | RAPAMYCIN CARBONATE ESTERS AS IMMUNOSUPPRESSANT AGENTS | AMERICAN HOME PROD (US) | 1997-04-16 | — | — | EP | disclosed |
| US-5610252-A | Vinyl carbonate and vinyl carbamate contact lens material monomers | BAUSCH & LOMB INCORPORATED (US) | 1997-03-11 | — | — | US | disclosed |
| US-5607691-A | IONTOPHORESIS | AFFYMAX TECHNOLOGIES N.V. (GB) | 1997-03-04 | — | — | US | disclosed |
| US-5605932-A | Opiate receptor ligands | CHIRON CORPORATION (US) | 1997-02-25 | — | — | US | disclosed |
| WO-1996040201-A1 | COMBINATORIAL LIBRARIES OF SUBSTRATE-BOUND CYCLIC ORGANIC COMPOUNDS | CHIRON CORPORATION (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040202-A1 | SYNTHESIS OF N-SUBSTITUTED OLIGOMERS | CHIRON CORPORATION (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040739-A2 | URETHANE MEDIATED, GST SPECIFIC MOLECULAR RELEASE SYSTEMS | TERRAPIN TECHNOLOGIES, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-5536868-A | Opiate receptor ligands | CHIRON CORPORATION (US) | 1996-07-16 | — | — | US | disclosed |
| WO-1996020921-A1 | OPIATE RECEPTOR LIGANDS | CHIRON CORPORATION (US) | 1996-07-11 | — | — | WO | disclosed |
| US-5481020-A | Opiate receptor ligands | CHIRON CORPORATION (US) | 1996-01-02 | — | — | US | disclosed |
| CN-1108935-A | Composition preparation containing quinoxaline and nucleoside | HOECHST AG (DE) | 1995-09-27 | — | — | CN | disclosed |
| EP-0671928-A1 | SYNTHESIS OF N-SUBSTITUTED OLIGOMERS | CHIRON CORPORATION (US) | 1995-09-20 | — | — | EP | disclosed |
| EP-0669923-A1 | RAPAMYCIN CARBONATE ESTERS AS IMMUNOSUPPRESSANT AGENTS. | AMERICAN HOME PROD (US) | 1995-09-06 | — | — | EP | disclosed |
| EP-0641337-A1 | CYCLIC ALKYLIDENE SUBSTITUTED PYRIDINE HERBICIDES | ROHM AND HAAS COMPANY (US) | 1995-03-08 | — | — | EP | disclosed |
| US-5348762-A | Process for the production of conductive layers | CIBA-GEIGY CORPORATION (US) | 1994-09-20 | — | — | US | disclosed |
| WO-1994011380-A1 | RAPAMYCIN CARBONATE ESTERS AS IMMUNOSUPPRESSANT AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1994-05-26 | — | — | WO | disclosed |
| WO-1994006451-A1 | SYNTHESIS OF N-SUBSTITUTED OLIGOMERS | CHIRON CORPORATION (US) | 1994-03-31 | — | — | WO | disclosed |
| US-5260300-A | Useful in treatment of transplant rejection; administering | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0528172-A1 | (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists | J. URIACH & CIA. S.A. (ES) | 1993-02-24 | — | — | EP | disclosed |
| US-5187293-A | Blood platelet activating factor inhibitors | HOFFMANN-LA ROCHE INC. (US) | 1993-02-16 | — | — | US | disclosed |
| WO-1992021674-A1 | CYCLIC ALKYLIDENE SUBSTITUTED PYRIDINE HERBICIDES | MONSANTO COMPANY (US) | 1992-12-10 | — | — | WO | disclosed |
| US-5156670-A | Low soil mobility | MONSANTO COMPANY (US) | 1992-10-20 | — | — | US | disclosed |
| US-5153321-A | Tetrathionaphthalene, tetraselenonaphthalene, tetratelluro-naphthalene, tetrathiotetracene, tetraselenotetracene, or tetratellurotetracene compounds for charge-transfer complexes | CIBA-GEIGY CORPORATION (US) | 1992-10-06 | — | — | US | disclosed |
| US-5096780-A | ELECTRICALLY CONDUCTIVE COATING COMPRISING A NEEDLE NETWORK OF CHANGE TRANSFER COMPLEXES | CIBA-GEIGY CORPORATION (US) | 1992-03-17 | — | — | US | disclosed |
| US-5077156-A | ANTISTATIC AND ELECTRICALLY CONDUCTIVE RELIEF IMAGES, PROCESSES FOR THE PRODUCTION THEREOF, COATING AGENTS AND RADIATION-SENSITIVE POLYMERS | CIBA-GEIGY CORPORATION (US) | 1991-12-31 | — | — | US | disclosed |
| US-5070215-A | Gas permeable contact lenses | BAUSCH & LOMB INCORPORATED (US) | 1991-12-03 | — | — | US | disclosed |
| US-5009812-A | Forming charge transfer complexes | CIBA-GEIGY CORPORATION (US) | 1991-04-23 | — | — | US | disclosed |
| EP-0396364-A2 | Novel vinyl carbonate and vinyl carbamate contact lens material monomers | BAUSCH & LOMB INCORPORATED (US) | 1990-11-07 | — | — | EP | disclosed |
| CN-1033631-A | Epipodophyllotoxin glucoside 4 '-acyl derivative | BRISTOL MYERS CO (US) | 1989-07-05 | — | — | CN | disclosed |
| US-4731373-A | BLOOD PLATELET ACTIVATING FACTOR | HOFFMAN-LA ROCHE INC. (US) | 1988-03-15 | — | — | US | disclosed |
| EP-0116999-B1 | PESTICIDAL NITROMETHYLENE DERIVATES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-01-20 | — | — | EP | disclosed |
| CN-85105429-A | The preparation desugar is the method for the carboxylates derivatives of Aaron Copland peaceful (deglucoteicoplanin) too | — | 1987-01-14 | — | — | CN | disclosed |
| EP-0116999-A1 | Pesticidal nitromethylene derivates | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1984-08-29 | — | — | EP | disclosed |
| US-4415571-A | HYPOTENSIVE AGENTS; THROMBOSIS; ANTICOAGULANTS; CARDIOVASCULAR DISORDDERS | BASF AKTIENGESELLSCHAFT (DE) | 1983-11-15 | — | — | US | disclosed |
| US-4376731-A | 2-NITRILES THEREOF | BOEHRINGER MANNHEIM GMBH (DE) | 1983-03-15 | — | — | US | disclosed |
| US-4234572-A | AMINOGLYCOSIDE ANTIBIOTICS | BAYER AKTIENGESELLSCHAFT (DE) | 1980-11-18 | — | — | US | disclosed |
| US-4111933-A | PROTECTION OF FUNCTIONAL GROUPS DURING REACTION AND THEIR SUBSEQUENT RESTORATION | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-05 | — | — | US | disclosed |
| US-4040812-A | Herbicidal carbonates and thiocarbonates of thiadiazolyl-2(1H)-pyrimidinones | VELSICOL CHEMICAL CORPORATION (US) | 1977-08-09 | — | — | US | disclosed |
| US-3998816-A | 7-[5-N-(n-Butoxyethoxy carbonyl and 2-chloroethoxy carbonyl)-amino] cephalosporins C | MEIJI SEIKA KAISHA, LTD. (JA) | 1976-12-21 | — | — | US | disclosed |
| US-3932465-A | ANTIBIOTIC | CIBA-GEIGY CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |
| US-3932465-A | ANTIBIOTIC | CIBA-GEIGY CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |